Prostate Cancer

AUA: Pandemic Disruptions Impacted One in Four Prostate, Bladder Cancer Patients

Publish Date May 18, 2022

Changes, delays, and cancellation of cancer treatment and ancillary care reported.

Trials Supporting Cancer Drug Approvals Lack Information on Gender

By

John Schieszer, MA

Publish Date May 16, 2022

Of more than 100 studies used to support drug approvals, none reported information on the gender of participants.

Risk of Cancer-Specific Death May Remain Elevated for 30 Years

By

Victoria Forster, PhD

Publish Date May 12, 2022

Patients with certain cancers have an increased risk of cancer-specific mortality that persists for 30 to 35 years after diagnosis.

Proton Beam Therapy Increasingly Used to Treat Cancers, Even When Evidence of Effectiveness Is Lacking

By

John Schieszer, MA

Publish Date May 11, 2022

The use of proton beam therapy (PBT) increased between 2004 and 2018, particularly for cancers in which the effectiveness of PBT is still under investigation.

Orteronel Does Not Improve Overall Survival in Prostate Cancer

By

Jonathan Goodman, MPhil

Publish Date May 9, 2022

Orteronel is likely not effective when compared with recently approved agents, according to researchers.

Prostate Cancer Resources

Clinical Trials

Drug Monographs

Fact Sheets